Brigitte Liberman

Brigitte Liberman: 

Hello, I’m delighted to be here today to present the outstanding results of the Active Cosmetics Division in 2020. I would also like to take this opportunity to introduce you to Myriam Cohen-Welgryn, who has been working with me since May and who is taking over from me as head of the Division. With solid international experience in brand development, portfolio management and operational management of business units, she is a woman with a strong strategic vision and business sense.

Myriam Cohen-Welgryn: 

Thanks Brigitte. I am delighted to be taking over from you at the head of this fantastic Division. I will be just as committed to pursuing the major growth drivers that have led to success in the past, while at the same time continuing to adapt to the huge changes taking place in the world around us.

Brigitte Liberman: 

The Division set a new record this year, achieving its best annual growth in more than 20 years, which is quite an achievement given the health and economic situation in 2020 and the low growth rate of the dermocosmetics market. Following several years of strong growth, the Division continued to win market shares in all Zones, especially the United States and Asia, with double-digit growth of its medical brands: CeraVe, SkinCeuticals and La Roche-Posay.

Myriam Cohen-Welgryn: 

First of all, our brand portfolio addresses more than ever the current concerns of consumers seeking to tend more actively to their health. In the context of the Covid crisis, our products for cleansing, protecting and taking care of the skin have been particularly relevant and have been incredibly successful. Furthermore, the situation has given more importance to healthcare professionals and therefore the strength of our business model, which is founded on close, trust-based partnerships with doctors and pharmacists. The latter have been at the forefront in recommending and prescribing our products. And finally, we quickly and radically adapted our activities, thanks to the commitment and agility of our teams worldwide, who managed to reinvent themselves. This was backed by the successful digital engagement of communities around our brands, and incredible sales in 2020 thanks to our expertise in e-commerce.

Brigitte Liberman: 

I am especially proud of the responsiveness and generosity that all our employees demonstrated in the fight against the pandemic. All our brands and all our countries participated. In Europe, we donated 20,000 hand creams. In our Vichy factory, 10 million bottles of hand sanitiser were produced, of which more than a million were distributed free of charge. Locally, in the city of Vichy, plant employees even mobilised to distribute these gels to hospitals, doctors and nursing homes. And finally, we undertook many actions to support healthcare professionals.

Myriam Cohen-Welgryn: 

In a market where, more than ever, “health is the future of beauty”, I am confident in our ability to grow our entire brand portfolio and continue to balance our geographic footprint. We will be able to capitalise on our digital and e-commerce expertise and rely on our partnerships with healthcare professionals.